The Phase 1 trial of the second-generation triterpenoid antifungal SCY-247, initiated in December of 2024, continues and results are expected in Q3 of 2025. Four presentations for SCY-247 were ...

A new study showed that psoriasis patients were 1.68 times more likely to acquire onychomycosis than people without psoriasis ...

Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) - a ...

The tool developed at Tulane was tested in collaboration with samples from University Health Network/University of Toronto, the Pneumonia Etiology Research for Child Health (PERCH) study, and the ...

and the International Mycoses Prevention, Research, Implementation, Networks and Training (IMPRINT) consortium at the University of Cape Town. The research was supported by the National Institutes ...

The tool developed at Tulane was tested in collaboration with samples from University Health Network/University of Toronto, the Pneumonia Etiology Research for Child Health (PERCH) study, and the ...

Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg INDIANAPOLIS /PRNewswire/ -- Late-breaking results from Eli ...

Mycoses often start in the lungs following inhalation of fungal spores or on the skin due to localized colonization.

When a person has black or dark-colored mucus, they may have inhaled potentially harmful pollutants. Coughing up black mucus may also be due to an underlying infection or condition. Mucus serves ...